Frejd FY - Search Results

1

In Vivo Imaging of the Programmed Death Ligand 1 by ¹⁸F PET.

González Trotter DE, Meng X, McQuade P, Rubins D, Klimas M, Zeng Z, Connolly BM, Miller PJ, O'Malley SS, Lin SA, Getty KL, Fayadat-Dilman L, Liang L, Wahlberg E, Widmark O, Ekblad C, Frejd FY, Hostetler ED, Evelhoch JL. González Trotter DE, et al. Among authors: frejd fy. J Nucl Med. 2017 Nov;58(11):1852-1857. doi: 10.2967/jnumed.117.191718. Epub 2017 Jun 6. J Nucl Med. 2017. PMID: 28588151 Free article.

2

Affibody molecules for epidermal growth factor receptor targeting in vivo: aspects of dimerization and labeling chemistry.

Tolmachev V, Friedman M, Sandström M, Eriksson TL, Rosik D, Hodik M, Ståhl S, Frejd FY, Orlova A. Tolmachev V, et al. Among authors: frejd fy. J Nucl Med. 2009 Feb;50(2):274-83. doi: 10.2967/jnumed.108.055525. Epub 2009 Jan 21. J Nucl Med. 2009. PMID: 19164241 Free article.

3

Site-specific radiometal labeling and improved biodistribution using ABY-027, a novel HER2-targeting affibody molecule-albumin-binding domain fusion protein.

Orlova A, Jonsson A, Rosik D, Lundqvist H, Lindborg M, Abrahmsen L, Ekblad C, Frejd FY, Tolmachev V. Orlova A, et al. Among authors: frejd fy. J Nucl Med. 2013 Jun;54(6):961-8. doi: 10.2967/jnumed.112.110700. Epub 2013 Mar 25. J Nucl Med. 2013. PMID: 23528382 Free article.

4

Imaging of platelet-derived growth factor receptor β expression in glioblastoma xenografts using affibody molecule 111In-DOTA-Z09591.

Tolmachev V, Varasteh Z, Honarvar H, Hosseinimehr SJ, Eriksson O, Jonasson P, Frejd FY, Abrahmsen L, Orlova A. Tolmachev V, et al. Among authors: frejd fy. J Nucl Med. 2014 Feb;55(2):294-300. doi: 10.2967/jnumed.113.121814. Epub 2014 Jan 9. J Nucl Med. 2014. PMID: 24408895 Free article.

5

An engineered affibody molecule with pH-dependent binding to FcRn mediates extended circulatory half-life of a fusion protein.

Seijsing J, Lindborg M, Höidén-Guthenberg I, Bönisch H, Guneriusson E, Frejd FY, Abrahmsén L, Ekblad C, Löfblom J, Uhlén M, Gräslund T. Seijsing J, et al. Among authors: frejd fy. Proc Natl Acad Sci U S A. 2014 Dec 2;111(48):17110-5. doi: 10.1073/pnas.1417717111. Epub 2014 Nov 18. Proc Natl Acad Sci U S A. 2014. PMID: 25406323 Free PMC article.

6

Same-Day Imaging Using Small Proteins: Clinical Experience and Translational Prospects in Oncology.

Krasniqi A, D'Huyvetter M, Devoogdt N, Frejd FY, Sörensen J, Orlova A, Keyaerts M, Tolmachev V. Krasniqi A, et al. Among authors: frejd fy. J Nucl Med. 2018 Jun;59(6):885-891. doi: 10.2967/jnumed.117.199901. Epub 2018 Mar 15. J Nucl Med. 2018. PMID: 29545374 Free article. Review.

7

In Vivo Evaluation and Dosimetry Estimate for a High Affinity Affibody PET Tracer Targeting PD-L1.

Rubins DJ, Meng X, McQuade P, Klimas M, Getty K, Lin SA, Connolly BM, O'Malley SS, Haley H, Purcell M, Gantert L, Holahan M, Lindgren J, Eklund P, Ekblad C, Frejd FY, Hostetler ED, González Trotter DE, Evelhoch JL. Rubins DJ, et al. Among authors: frejd fy. Mol Imaging Biol. 2021 Apr;23(2):241-249. doi: 10.1007/s11307-020-01544-2. Epub 2020 Oct 23. Mol Imaging Biol. 2021. PMID: 33098025

8

Biologic Evaluation of a Heterodimeric HER2-Albumin Targeted Affibody Molecule Produced by Chemo-Enzymatic Peptide Synthesis.

Liu Y, Güler R, Liao Y, Vorobyeva A, Widmark O, Meuleman TJ, Koijen A, van den Bos LJ, Naasz R, Bodenko V, Orlova A, Ekblad C, Tolmachev V, Frejd FY. Liu Y, et al. Among authors: frejd fy. Pharmaceutics. 2022 Nov 19;14(11):2519. doi: 10.3390/pharmaceutics14112519. Pharmaceutics. 2022. PMID: 36432709 Free PMC article.

9

Human Epidermal Growth Factor Receptor 2-Targeting [⁶⁸Ga]Ga-ABY-025 PET/CT Predicts Early Metabolic Response in Metastatic Breast Cancer.

Alhuseinalkhudhur A, Lindman H, Liss P, Sundin T, Frejd FY, Hartman J, Iyer V, Feldwisch J, Lubberink M, Rönnlund C, Tolmachev V, Velikyan I, Sörensen J. Alhuseinalkhudhur A, et al. Among authors: frejd fy. J Nucl Med. 2023 Sep;64(9):1364-1370. doi: 10.2967/jnumed.122.265364. Epub 2023 Jul 13. J Nucl Med. 2023. PMID: 37442602 Free PMC article. Clinical Trial.

10

Phase I clinical evaluation of ^99mTc-labeled Affibody molecule for imaging HER2 expression in breast cancer.

Bragina O, Chernov V, Larkina M, Rybina A, Zelchan R, Garbukov E, Oroujeni M, Loftenius A, Orlova A, Sörensen J, Frejd FY, Tolmachev V. Bragina O, et al. Among authors: frejd fy. Theranostics. 2023 Sep 4;13(14):4858-4871. doi: 10.7150/thno.86770. eCollection 2023. Theranostics. 2023. PMID: 37771776 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

62 results

Search Page